The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.
暂无分享,去创建一个
G. Raghu | J. Behr | R. D. du Bois | K. Brown | F. Wamboldt | T. King | J. Swigris
[1] D. Lynch,et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[2] G. Raghu,et al. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. , 2010, Respiratory medicine.
[3] A. Holland,et al. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. , 2009, Respiratory medicine.
[4] G. Raghu,et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. , 2008, American journal of respiratory and critical care medicine.
[5] R. D. Bois,et al. CATEGORICAL DECLINES IN PERCENT PREDICTED FORCED VITAL CAPACITY (PP-FVC) ARE ASSOCIATED WITH A GRADED RISK OF DEATH IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) , 2008 .
[6] H. Schünemann,et al. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease , 2008, Health and quality of life outcomes.
[7] Y. Kondoh,et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis , 2008, Respirology.
[8] Sally J. Singh,et al. Minimum clinically important improvement for the incremental shuttle walking test , 2008, Thorax.
[9] G. Raghu,et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.
[10] Y. Kondoh,et al. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. , 2007, Respiratory medicine.
[11] K. Imanaka,et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis--cross-sectional and longitudinal study. , 2007, Internal medicine.
[12] F. Martinez,et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. , 2006, American journal of respiratory and critical care medicine.
[13] A. Stewart,et al. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives , 2005, Health and quality of life outcomes.
[14] M. Gould,et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review , 2005, Thorax.
[15] A. Wells,et al. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.
[16] S. Kudoh,et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.
[17] Y. Kondoh,et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? , 2005, Respiratory medicine.
[18] D. Mahler,et al. The MCID of the Transition Dyspnea Index is a Total Score of One Unit , 2005, COPD.
[19] R. Hays,et al. Approaches and Recommendations for Estimating Minimally Important Differences for Health-Related Quality of Life Measures , 2005, COPD.
[20] Cynthia D. Brown,et al. Minimal Clinically Important Differences in the Six-Minute Walk Test and the Incremental Shuttle Walking Test , 2005, COPD.
[21] L. Léger,et al. A maximal multistage 20-m shuttle run test to predict $$\dot V$$ O2 max , 2004, European Journal of Applied Physiology and Occupational Physiology.
[22] G. Guyatt,et al. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. , 2003, Journal of clinical epidemiology.
[23] A. Nicholson,et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. , 2003, American journal of respiratory and critical care medicine.
[24] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[25] F. Martinez,et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.
[26] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[27] J. Brazier,et al. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.
[28] U. Costabel,et al. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002, European Respiratory Journal.
[29] ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.
[30] J. Tooze,et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.
[31] R. Hubbard,et al. A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis , 2001, Thorax.
[32] A. Pardo,et al. Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.
[33] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[34] James C. Raymondo,et al. Statistical Analysis in the Behavioral Sciences , 1998 .
[35] G H Guyatt,et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.
[36] M. Muers,et al. Reproducibility of walking test results in chronic obstructive airways disease. , 1988, Thorax.
[37] G. Guyatt,et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.
[38] G H Guyatt,et al. How should we measure function in patients with chronic heart and lung disease? , 1985, Journal of chronic diseases.
[39] G H Guyatt,et al. Effect of encouragement on walking test performance. , 1984, Thorax.
[40] C. Wells,et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.
[41] A. Woodcock,et al. Two-, six-, and 12-minute walking tests in respiratory disease. , 1982, British medical journal.
[42] A H Morris,et al. Standardized single breath normal values for carbon monoxide diffusing capacity. , 2015, The American review of respiratory disease.
[43] J. Morris,et al. Spirometric standards for healthy nonsmoking adults. , 2015, The American review of respiratory disease.
[44] D L Adams,et al. Analysis of a life satisfaction index. , 1969, Journal of gerontology.